Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Progress in the diagnosis of endocrine and metabolic disorders: hyperlipidemia].

Rinsho byori. The Japanese journal of clinical pathology - 1 Nov 1995

Yamashita S

Abstract excerpt

Hyperlipidemia is one of the risk factors for coronary atherosclerosis and the establishment of its simple etiological diagnosis is crucial. Hyperlipidemia can be classified into primary and secondary hyperlipidemia. Primary hyperlipidemia includes familial lipoprotein lipase (LPL) deficiency, familial hypercholesterolemia (FH), familial type III hyperlipidemia, and familial combined hyperlipidemia. Many genetic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carrier Proteins
Share to Cholesterol Ester Transfer Proteins
Share to LPL gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Glycoproteins

Share to Hyperlipidemias

Share to Lipoprotein(a)

Share to Mutation

Share to Receptors, LDL

Source

Identifiers

PMID: 8551675

Genes

LPL
CETP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Progress in the diagnosis of endocrine and metabolic disorders: hyperlipidemia].PMID 8551675Read ↗

[New approach to pathogenesis of genetic hyperlipoproteinemias].Semantic proximity Read ↗

Molecular mechanisms, prevalence, and molecular methods for familial combined hyperlipidemia disease: A reviewSemantic proximity Read ↗

[Molecular genetics of hyperlipidemia].Semantic proximity Read ↗

[Advances in diagnosis and treatment of familial hypercholesterolemia].Semantic proximity Read ↗

[Pathogenesis of hypolipidemia].Semantic proximity Read ↗

[Genetic basis for dyslipidemias].Semantic proximity Read ↗

[Genetic aspects of hyperlipidemia].Semantic proximity Read ↗

[Molecular biology of hyperlipidemias. Genetic variation of apolipoproteins].Semantic proximity Read ↗

[Hyperlipoproteinemia type III: genetic basis and environmental factors, diagnosis, and treatment].Semantic proximity Read ↗

Mutations in Japanese subjects with primary hyperlipidemia--results from the Research Committee of the Ministry of Health and Welfare of Japan since 1996--.Semantic proximity Read ↗

Familial combined hyperlipidemia: An overview of the underlying molecular mechanisms and therapeutic strategiesSemantic proximity Read ↗

[Abnormalities of apolipoprotein E (type III hyperlipoproteinemia)].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.